[{"AccountsPayableCurrent_0_Q2_USD":10434000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":65495000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":310000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":95000.0,"StockRepurchasedAndRetiredDuringPeriodShares_2_Q2_shares":300000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":26000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":289373.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q2_shares":4020516.0,"OtherAssetsNoncurrent_0_Q2_USD":51000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":231000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1266000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":7663000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":269000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":271000.0,"ShareBasedCompensation_2_Q2_USD":2732000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17906000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":30277000.0,"PreferredStockValue_0_Q2_USD":null,"OtherLiabilitiesCurrent_0_Q2_USD":1128000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2732000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":101000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":907000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":194000.0,"OperatingLeaseLiability_0_Q2_USD":1101000.0,"OperatingLeaseCost_2_Q2_USD":108000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":149000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":105000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":196000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":219000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":225000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":230000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":275000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1250000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":33069000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1956000.0,"AccruedInsuranceCurrent_0_Q2_USD":934000.0,"AccruedIncomeTaxes_0_Q2_USD":0.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":16000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1184000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LiabilitiesCurrent_0_Q2_USD":16161000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":70462000.0,"Liabilities_0_Q2_USD":17068000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1137000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3529000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6154000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.06,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.85,"CommonStockValue_0_Q2_USD":20000.0,"CommonStockSharesOutstanding_0_Q2_shares":20352913.0,"CommonStockSharesIssued_0_Q2_shares":20352913.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":65495000.0,"AssetsCurrent_0_Q2_USD":68313000.0,"Assets_0_Q2_USD":70462000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":3223450.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3143233.0,"AdditionalPaidInCapital_0_Q2_USD":146392000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":60097000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-51000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-26977000.0,"NetIncomeLoss_2_Q2_USD":-36330000.0,"OperatingIncomeLoss_1_Q2_USD":-21435000.0,"OperatingIncomeLoss_2_Q2_USD":-36431000.0,"OperatingExpenses_1_Q2_USD":21435000.0,"OperatingExpenses_2_Q2_USD":36431000.0,"InterestPaidNet_2_Q2_USD":18000.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AccruedLiabilitiesCurrent_0_Q2_USD":4527000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1101000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":20293216.0,"StockholdersEquity_0_Q2_USD":53394000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-93018000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":997000.0,"ProfitLoss_2_Q2_USD":-36330000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":68811000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2818000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":51000.0,"NetIncomeLoss_1_Q2_USD":-21419000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":19619145.0,"PaymentsForRepurchaseOfEquity_2_Q2_USD":9024000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200814"}]